MBRX
Moleculin Biotech, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Walter V. Klemp
IPO Date
2016-06-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Moleculin Biotech, Inc.
CEO
Walter V. Klemp
IPO Date
2016-06-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 200,000 |
| $0.00 |
| 14 Nov 2025 | Foster Jonathan P. | EVP & CFO | A-Award | Acquired | 600,000 | $0.49 |
| 14 Nov 2025 | Foster Jonathan P. | EVP & CFO | A-Award | Acquired | 400,000 | $0.00 |
| 14 Nov 2025 | KLEMP WALTER V | director, officer: CEO and President | A-Award | Acquired | 830,000 | $0.49 |
| 14 Nov 2025 | KLEMP WALTER V | director, officer: CEO and President | A-Award | Acquired | 750,000 | $0.00 |
| 14 Nov 2025 | Yan Joy | director | A-Award | Acquired | 150,000 | $0.49 |
| 14 Nov 2025 | Cermak Elizabeth | director | A-Award | Acquired | 150,000 | $0.49 |
| 14 Nov 2025 | CANNON MICHAEL D | director | A-Award | Acquired | 150,000 | $0.49 |
| 14 Nov 2025 | Climaco John M | director | A-Award | Acquired | 150,000 | $0.49 |